Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNAH10OS encodes a putative, uncharacterized RNA gene believed to represent the *opposite (i.e., antisense)* strand of the well-studied DNAH10 (Dynein axonemal heavy chain 10) locus[5]. DNAH10OS is cataloged as a long noncoding RNA (lncRNA) and may not produce a protein. Its function is unknown, and there is no evidence it encodes a receptor, enzyme, transporter, or other typical drug target[5]. DNAH10OS is categorized among so-called "orphan" or "de novo" genes, typically with short predicted open reading frames, often lacking significant expression patterns or disease association[4]. No functional roles, therapeutic relevance, or associations with pharmacological agents have been established for DNAH10OS[5]. DNAH10OS (Dynein axonemal heavy chain 10 opposite strand) is a poorly characterized, likely non-protein-coding locus with no established molecular function, disease relevance, or therapeutic targeting[4][5]. Its annotation is based on genomic position opposite to DNAH10, and it should not be confused with the well-studied dynein heavy chain.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dynein axonemal heavy chain 10 opposite strand (DNAH10OS).